4th Quarter - Termination
CAPITOL CONSULTING GROUP, LLC for TERUMO BCT (FORMERLY CARIDIANBCT BIOTECHNOLOGIES LLC)
Income
$20,000
Expenses
—
Terminated
Dec 31, 2012
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Defense DEF
Blood pathogen reduction technology development
Foreign entity interest: Owner
| Lobbyist | Covered position, as disclosed |
|---|---|
| GILLIAN JAEGER | — |
Medical/Disease Research/Clinical Labs MED
Blood pathogen reduction technology develoopment
Foreign entity interest: Owner
| Lobbyist | Covered position, as disclosed |
|---|---|
| GILLIAN JAEGER | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| TERUMO CORPORATION | Japan | Japan | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.